Peter and Takako Jones Lab

Peter and Takako Jones Lab

Welcome to the Peter and Takako Jones Lab. Our primary research focus is on facioscapulohumeral muscular dystrophy (FSHD). FSHD is the most prevalent muscular dystrophy that affects males and females, children and adults. There are both genetic components and epigenetic aspects that correlate with the highly variable levels of disease severity and progression. Currently there is no cure and there are no ameliorative treatments. We are developing novel therapeutics for FSHD including small molecule inhibition, ncRNAs and CRISPR-based approaches. In addition, we use FSHD as a model to investigate epigenetic mechanisms of gene regulation.

About Our Lab

About Our Lab

Learn more about the research we do in Nevada on muscular dystrophy and how we are working to develop medical treatments.

Research

Research

The most common muscular dystrophy today is facioscapulohumeral—and we're trying to treat it.

Community Outreach

Community Outreach

The Jones Lab is committed to finding a cure to FSHD, so we communicate with the public about this disease.